TITLE

Promising Detox Therapy

PUB. DATE
April 2009
SOURCE
PN;Apr2009, Vol. 63 Issue 4, p36
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the study conducted by the Amyotrophic Lateral Sclerosis (ALS) Association concerning the significance of natural detoxification therapy on ALS patients in the U.S. Lead scientist Jeffrey Johnson from the University of Wisconsin discovered through mouse models with human gene for a familial type of ALS, that detoxification is effective against the chronic neuron-killing characteristic of ALS. This significant finding could delay the onset of ALS, extending life span.
ACCESSION #
36869757

 

Related Articles

  • Pseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP). Tortelli, Rosanna; Copetti, Massimiliano; Arcuti, Simona; Tursi, Marianna; Iurillo, Annalisa; Barulli, Maria; Cortese, Rosa; Capozzo, Rosa; D'Errico, Eustachio; Marin, Benoit; Simone, Isabella; Logroscino, Giancarlo // Journal of Neurology;Feb2016, Vol. 263 Issue 2, p316 

    The aim of this study is to investigate the frequency and the clinical correlations of pseudobulbar affect (PBA) in a population-based incident cohort of ALS patients. Incident ALS cases, diagnosed in 2011 and 2012, according to El Escorial criteria were enrolled from a prospective...

  • Atypical familial amyotrophic lateral sclerosis with initial symptoms of pain or tremor in a Chinese family harboring VAPB-P56S mutation. Di, Li; Chen, Hai; Da, Yuwei; Wang, Suobing; Shen, Xin-Ming // Journal of Neurology;Feb2016, Vol. 263 Issue 2, p263 

    Amyotrophic lateral sclerosis (ALS) is the most prevalent fatal motor neuron disease and ~10 % of cases are hereditary. Mutations associated with ALS have been identified in more than 20 genes, but ALS type 8 (ALS8), which is caused by mutations in vesicle-associated membrane protein-associated...

  • Anesthetic management of the patient with amyotrophic lateral sclerosis. Prabhakar, Amit; Owen, Christopher Paul; Kaye, Alan David // Journal of Anesthesia;Dec2013, Vol. 27 Issue 6, p909 

    Amyotrophic lateral sclerosis (ALS), with an incidence of 1.5–2.5 for 100 000 per year, is a rare but rapid progression neuromuscular degeneration disorder that poses unique perioperatively challenges to clinical anesthesiologists. The progressive degeneration of motor neurons causes a...

  • The management of amyotrophic lateral sclerosis. Phukan, Julie; Hardiman, Orla // Journal of Neurology;Feb2009, Vol. 256 Issue 2, p176 

    The terms amyotrophic lateral sclerosis (ALS) or motor neuron disease (MND) refer to a condition characterized by motor system degeneration with relative preservation of other pathways. Although there have been advances in symptomatic treatment, ALS remains an incurable condition. Advances in...

  • Discovery into how ALS spreads.  // British Columbia Medical Journal;Apr2014, Vol. 56 Issue 3, p1 

    The article discusses a study led by University of British Columbia and Vancouver Coastal Health Research Institute, published in the "Proceedings of the National Academy of Sciences" on the transmission of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, from cell to...

  • Muscle Expression of SOD1G93A Modulates microRNA and mRNA Transcription Pattern Associated with the Myelination Process in the Spinal Cord of Transgenic Mice. Dobrowolny, Gabriella; Bernardini, Camilla; Martini, Martina; Baranzini, Mirko; Barba, Marta; Musarò, Antonio // Frontiers in Cellular Neuroscience;Dec2015, Vol. 9, p1 

    A crucial system severely affected in several neuromuscular diseases is the loss of effective connection between muscle and nerve, leading to a pathological non-communication between the two tissues. One of the best examples of impaired interplay between muscle and nerve is Amyotrophic Lateral...

  • Gastrostomía endóscopica percutánea en esclerosis lateral amiotrófica; experiencia en un hospital de tercer nivel. Prior-Sánchez, Inmaculada; Herrera-Martínez, Aura Dulcinea; Tenorio Jiménez, Carmen; Molina Puerta, María José; Calañas Continente, Alfonso; Manzano García, Gregorio; Gálvez Moreno, María Ángeles // Nutricion Hospitalaria;dec2014, Vol. 30 Issue 6, p1289 

    Background: Amyotrophic Lateral Sclerosis (ALS) is a degenerative disorder that affects the pyramidal tract, producing progressive motor dysfunctions leading to paralysis. These patients can present with dysphagia, requiring nutritional support with a nasogastric tube or Percutaneous Endoscopic...

  • Whole-Genome Analysis of Sporadic Amyotrophic Lateral Sclerosis. Dunckley, Travis; Huentelman, Matthew J.; Craig, David W.; Pearson, John V.; Szelinger, Szabolcs; Joshipura, Keta; Halperin, Rebecca F.; Stamper, Chelsea; Jensen, Kendall R.; Letizia, David; Hesterlee, Sharon E.; Pestronk, Alan; Levine, Todd; Bertorini, Tulio; Graves, Michael C.; Mozaffar, Tahseen; Jackson, Carlayne E.; Bosch, Peter; McVey, April; Dick, Arthur // New England Journal of Medicine;8/23/2007, Vol. 357 Issue 8, p775 

    Background: Approximately 90% of persons with amyotrophic lateral sclerosis (ALS) have the sporadic form, which may be caused by the interaction of multiple environmental factors and previously unknown genes. Methods: We performed a genomewide association analysis using 766,955 single-nucleotide...

  • Genetics of motor neuron disorders: new insights into pathogenic mechanisms. Dion, Patrick A.; Daoud, Hussein; Rouleau, Guy A. // Nature Reviews Genetics;Nov2009, Vol. 10 Issue 11, p769 

    The past few years have seen the identification of dozens of genes with causal roles in motor neuron diseases (MNDs), particularly for amyotrophic lateral sclerosis and hereditary spastic paraplegia. Although many additional MND genes remain to be identified, the accumulated genetic evidence has...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics